A ranked guide to the world's top 10 pharmaceutical manufacturing companies by 2025 drug revenue, with market value, home countries and the nations that make the medicines.
Eli Lilly is the world's most valuable drugmaker, worth about $1.3 trillion in November 2026. Johnson & Johnson still reports the biggest sales, at $94.2 billion for 2025.
That split explains why no list of pharmaceutical manufacturing companies is ever final. Rank by market value and Lilly wins. Rank by total revenue and J&J does. Strip out J&J's medical devices, and Lilly takes first place again on $65.2 billion in drug sales. This guide ranks the top pharmaceutical companies by 2025 drug revenue, explains what separates them and traces where the world's medicines are made, which is often not where the headquarters sits.
How are the top pharmaceutical companies ranked?
Analysts lean on three yardsticks: market capitalisation, total revenue and pharmaceutical only revenue. Each answers a different question. Market value measures investor expectations. Total revenue measures the whole corporation. Drug revenue isolates the medicines business.
This ranking uses the third. Fiscal 2025 reports are final, so the numbers hold still. Market caps do not. Capital.com's snapshot of May 5, 2026 valued Lilly at $863.1 billion, while Motley Fool's November 2026 list puts it near $1.3 trillion. A ranking that swings that fast is a photograph, not a verdict.
Who are the top 10 pharmaceutical manufacturing companies in the world?
Ranked by fiscal 2025 pharmaceutical revenue:
|
Rank |
Company |
Headquarters |
2025 pharma revenue |
|
1 |
Eli Lilly |
United States |
$65.2B |
|
2 |
Pfizer |
United States |
$62.6B |
|
3 |
AbbVie |
United States |
$61.2B |
|
4 |
Johnson & Johnson (Innovative Medicine) |
United States |
$60.4B |
|
5 |
AstraZeneca |
United Kingdom |
$58.7B |
|
6 |
Merck & Co. |
United States |
$58.1B |
|
7 |
Roche (Pharmaceuticals) |
Switzerland |
$57.6B |
|
8 |
Novartis |
Switzerland |
$54.5B |
|
9 |
Bristol Myers Squibb |
United States |
$48.2B |
|
10 |
Sanofi |
France |
$47.4B |
Six of the ten are American. Switzerland supplies two, the United Kingdom and France one each. The race at the top is tight: Lilly leads second placed Pfizer by just $2.6 billion. Two rows need a footnote. Roche's figure counts its pharmaceuticals division alone and the group reported CHF 61.5 billion in total. J&J's covers its Innovative Medicine segment only.
Why does the "largest" title keep changing hands?
It depends on what you count. J&J's total revenue of $94.2 billion includes $33.8 billion from medical devices; its drug business made $60.4 billion. Lilly's sales jumped 45% to $65.2 billion in 2025, from $45.0 billion a year earlier and its obesity and diabetes brands Mounjaro and Zepbound brought in about $36.5 billion between them.
Valuation tells a third story. On Motley Fool's November 2026 list, Lilly sits at $1.3 trillion and J&J at $640.8 billion. Now look at Pfizer. It ranks second on drug sales, yet Capital.com's May 5, 2026 table places it 11th by market cap, at $149.6 billion. Sales and valuation do not move in lockstep.
How dependent are the leading pharmaceutical manufacturers on one drug?
Heavily, in several cases.
Keytruda accounts for 54% of Merck's drug revenue, Dupixent 37% of Sanofi's, Mounjaro 35% of Lilly's and Skyrizi 29% of AbbVie's.
Our reading: a flagship product can lift a company up this table quickly, as Lilly's 45% jump shows, but it also means one drug's fortunes can reorder the list. Watch the biggest product, not just the total.
Where are the world's medicines actually made?
The name on the label rarely matches the address of the plant. Ireland shows it. A directory of Irish manufacturing sites compiled by Priya Life Science lists five for J&J and five for Merck & Co., spread across Carlow, Cork, Louth, Meath and Tipperary. The same directory shows Lilly producing in Kinsale, Cork, with a Limerick site not yet in production.
That spread is typical of global pharmaceutical companies: research and ownership in one country, production in another, sales everywhere.
Which countries lead the global pharmaceutical manufacturing industry?
Measured by export value, four European countries and the United States dominate. In 2023 the top exporters of pharmaceutical products were Germany, the United States, Ireland, Switzerland and Belgium.
|
Rank |
Country |
2023 pharmaceutical exports |
Top-10 drugmakers headquartered |
|
1 |
Germany |
$115B |
0 |
|
2 |
United States |
$100B |
6 |
|
3 |
Ireland |
$92B |
0 |
|
4 |
Switzerland |
$80.7B |
2 |
|
5 |
Belgium |
$52.1B |
0 |
Insights
Despite being large exporters, none of the top 10 pharmaceutical manufacturers’ headquarters are located in Germany, Ireland or Belgium.
Ireland was the biggest exporter of medicines and pharmaceuticals from the EU to countries outside of the EU in 2025, valued at €93.8 billion. Around 30% of Switzerland’s total exports come from pharmaceutical production. India also had notable results in 2023, exporting pharmaceuticals for a surplus of $24 billion (third highest after Ireland and Germany).
Further Information
-
$33.8 billion of J&J’s $94.2 billion revenue in 2025 was generated from MedTech.
-
Lilly increased revenue by 45% in 2025 to $65.2 billion.
-
Roche generated total revenue of CHF 61.5 billion in 2025.
-
Novo Nordisk ranked 8th in market cap on Capital.com on 5th May 2026, valued at $196.8 billion.
-
Amgen is the largest pure biotech company in the world.
-
Medicinal and pharmaceutical products were exported from the EU to other countries for a total of €366.2 billion in 2025. This resulted in a surplus of €220.5 billion as only €145.7 billion was imported.
-
Pharmaceutical trade deficits with Ireland and Switzerland in the US were $45.5 billion and $15.7 billion respectively (2024).
Depending on which metric is considered, the top pharmaceutical manufacturing companies are different. Eli Lilly is the largest pharmaceutical manufacturer in terms of drug sales and market cap. J&J is the largest in terms of overall revenue. The top 10 pharmaceutical manufacturing companies include 6 American companies, 2 from Switzerland, 1 from Britain and 1 from France. Despite this, much of the exporting comes from Germany, Ireland and Belgium. The metric, time frame and scope of each list should always be considered. Save this Business Fortune reference to help with next year’s results.
FAQs
1. What is the largest pharmaceutical company in the world?
Depending on the metric considered, this varies. J&J is the largest in terms of overall revenue ($94.2 billion in 2025). Eli Lilly has the highest drug revenue ($65.2 billion) and market cap (around $1.3 trillion in Nov 2026).
2. What are the largest pharmaceutical manufacturers in the world?
Top pharmaceutical manufacturers in 2025 by drug revenue: Eli Lilly, Pfizer, AbbVie, Johnson & Johnson, AstraZeneca, Merck & Co., Roche, Novartis, Bristol Myers Squibb, Sanofi.
3. Which countries are the largest pharmaceutical manufacturers in the world?
Top pharmaceutical manufacturing countries in 2023 by export value: Germany, United States, Ireland, Switzerland and Belgium. India had the third largest export surplus.
4. Is Johnson & Johnson a pharmaceutical manufacturer?
Yes. While $60.4 billion was generated from Innovative Medicines in 2025, $33.8 billion came from medical devices meaning $94.2 billion total revenue.
5. How much do the largest drug companies invest into research?
The largest 20 prescription drug companies generate a total of around $914 billion in revenue in fiscal year 2025. They have invested $175.5 billion into research and development. Lilly invested the most out of the top drugmakers, investing $13.34 billion (20.5% of revenue).















Comments